November 12, 2026
$RichWire Markets and money, explained simply
LIVE
AppLovin Rating Downgraded by Analyst Citing Valuation Concerns Despite Strong Growth Cisco Set to Report Fiscal First-Quarter Results After Market Close Nvidia Shares Slide Following CEO Jensen Huang's Departure KBC Group Reports €1.14 Billion Profit for Third Quarter 2026 Nvidia Stock Drops as CEO Jensen Huang Resigns Amid Security Scrutiny Salesforce Offers Investors Exposure to AI Leaders Slack and MuleSoft Evaluating the Vanguard S&P 500 ETF for the Next Bear Market Nvidia CEO Jensen Huang Resigns Amid Espionage Allegations and Export Control Scrutiny SpaceX Enters Mobile Market with Qualcomm Deal to Launch Starlink Mobile Solana-Based Meme Coin Myro Eyes Long-Term Outlook as Analysts Point to 2030 Goals Why Diversification Outperforms Market Timing in Factor Investing Acurx Pharmaceuticals Reports Third Quarter 2026 Financial Results AppLovin Rating Downgraded by Analyst Citing Valuation Concerns Despite Strong Growth Cisco Set to Report Fiscal First-Quarter Results After Market Close Nvidia Shares Slide Following CEO Jensen Huang's Departure KBC Group Reports €1.14 Billion Profit for Third Quarter 2026 Nvidia Stock Drops as CEO Jensen Huang Resigns Amid Security Scrutiny Salesforce Offers Investors Exposure to AI Leaders Slack and MuleSoft Evaluating the Vanguard S&P 500 ETF for the Next Bear Market Nvidia CEO Jensen Huang Resigns Amid Espionage Allegations and Export Control Scrutiny SpaceX Enters Mobile Market with Qualcomm Deal to Launch Starlink Mobile Solana-Based Meme Coin Myro Eyes Long-Term Outlook as Analysts Point to 2030 Goals Why Diversification Outperforms Market Timing in Factor Investing Acurx Pharmaceuticals Reports Third Quarter 2026 Financial Results

Acurx Pharmaceuticals Reports Third Quarter 2026 Financial Results

🏢 Companies 1 min read 👁 0

Acurx Pharmaceuticals released its third quarter 2026 financial results and corporate updates during an earnings call on November 12, 2026.

Acurx Pharmaceuticals Reports Third Quarter 2026 Financial Results🏢Companies

Photo: Seeking Alpha

Key points

  • Acurx Pharmaceuticals held its Q3 2026 earnings call on November 12, 2026.
  • President and CEO David Luci and CFO Robert Shawah presented the financial results and corporate outlook.
  • The company filed its Form 10-Q quarterly report with the SEC.

Acurx Pharmaceuticals, Inc. hosted its third quarter 2026 financial results conference call on November 12, 2026, detailing corporate updates and financial highlights for the period ending September 30, 2026. Company executives, including President and CEO David Luci and Co-Founder and CFO Robert Shawah, led the morning discussion outlining the firm's recent progress.

During the session, leadership highlighted operational milestones and reviewed key financial metrics outlined in the official press release available on the company's website. Alongside the earnings update, management formally filed the quarterly report on Form 10-Q with the Securities and Exchange Commission.

Executives reminded participants that the discussion included forward-looking statements regarding future expectations and business operations. Investors were advised to review the company's SEC filings for a comprehensive breakdown of the various risks and uncertainties that could influence future performance.

Source Seeking Alpha — seekingalpha.com/article/4967016-acurx-pharmaceuticals-inc-acxp-q3-2026… ↗

Contact the newsroom

Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.